Elicera Therapeutics (OMX: ELIC)

Last close As at 06/02/2026

SEK5.27

0.24 (4.77%)

Market capitalisation

SEK245m

Elicera Therapeutics is a Sweden-based clinical-stage cell and gene therapy company focused on developing next generation immuno-oncology treatments based on iTANK-armed oncolytic viruses and CAR-T cells.

Latest Insights

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Director, healthcare

Key Management

  • Ingvar Karlsson

    CFO

  • Jamal El-Mosleh

    CEO and co-founder